Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Protox Therapeutics Inc T.PRX

TSX:PRX - Post Discussion

Protox Therapeutics Inc > Six Month Report??
View:
Post by sanduf on Sep 07, 2010 5:49pm

Six Month Report??

This is the time frame for the 9 month report for the Protox experiment. Does anoyone have any information at all? I know that my 9th month results were off the scale on the IPSS. I was in my teenage years of performance in all cetegories at that point. It went downhill a bit to month 12 but was still much improved over my initial IPSS score.

I can only comment that the protox treatment did not retard the growth of my prostate in that it was 54 measurable units in April/09 and 60 measurable units in July/10 when I started my current drug experiment and the old symptoms are back in full force. That is why I would gladly pay for the treatment out of my own pocket every nine months if necessary for the relief it gave to me and the pleasure it allowed me to give to my spouse.
Comment by bioboy10 on Sep 08, 2010 10:57pm
I think the time frame for the 6 month report was summer, we are all waiting for the 12 month out data which should be out in the next month.anyone hearing anything. Stock has good support...hope you feel better sanduf...
Comment by cabbieJBJ on Sep 10, 2010 7:49am
Q4 is the target for the 12-month data from 2b.  More important tho imo is the end of Phase 2 meeting with the FDA and Euro Zone reviewers and the issue of the IND (and its Euro Zone equivalent) as this will establish the parameters for Phase 3, set the preferred clinical/business strategies and hence PRX's funding needs and/or partner opportunities.  Also ...more